LaBranche to launch strategic review, shares up
687439
LaBranche & Co. Inc. , which runs one of the largest equity specialist trading operations on the floor of the New York Stock Exchange, said on Monday it would begin a strategic review of the company, sending its shares up more than 5 percent in morning trading.
618506
French equities look well placed to post tidy gains in 2005, with the benchmark CAC-40 index seen rising to around 4,100-4,200 points, bolstered by increased merger and acquisitions activity and attractive valuations, analysts said.
471781
The company is ready to handle competition from generics.
697002
Brokerage LaBranche &amp; Co. on Monday said it swung to a loss in the third quarter on lower equity volumes and volatility at its specialist unit.
574946
BlackBerry maker Research In Motion   Ltd. RIMM.O announced on Thursday that its audit   committee would voluntarily review historical stock-option   grants to employees, and has determined that a restatement of   its financials might be required.
238390
The company may be hinting at going public.
553993
The company said quarterly profit would be higher than analystsâ estimates and it raised its full-year outlook as exchange rates and price and volume increases offset high commodity costs.
328806
Shares of Protein Design Labs Inc (PDLI.O: Quote, Profile, Research) rose on Thursday after Swiss drugmaker Roche Holding AG (ROG.
534729
Credit Suisse will seek to launch a  share buyback plan worth up to 6 billion Swiss francs ($5  billion), it said on Thursday, after reporting a better than  expected 22 percent rise in fourth-quarter net profits.
645112
Leading stock market indexes looked set to open higher on Wednesday with focus on investment bank Morgan Stanley's  quarterly results.
79284
Investigation-raised questions lead computer maker to hold up regulatory filing; federal prosecutor begins a related probe.
28584
Blackstone Group LP, manager of the world's second-largest buyout fund, moved up its much-hyped $4.75 billion initial public offering to this week amid growing scrutiny of the firm on Capitol Hill and in the media.
130111
U.S. shares look set to open higher  on Wednesday with technology shares in focus after  better-than-expected results from Cisco  on Tuesday,  while investors also eye U.S. labor cost data.
595644
The British drugmaker looks to regain momentum this year.
519863
The company faces a pivotal clinical trial.
399868
Company registers strong start for a lineup of investment bank quarterly earnings releases.
252423
U.S. shares look set to open higher on Wednesday with technology shares in focus after better-than-expected results from Cisco  on Tuesday, while investors also eye U.S. labor cost data.